Clora’s Post

We believe standardization is the key to achieving better patient care and access. In our a recent episode of the BioProcess International podcast, Josh Ludwig explored how a standardized manufacturing model can help address industry challenges and improve patient outcomes. Listen to the full conversation to learn how ScaleReady is driving this change: https://lnkd.in/gnpNKDPa #biotech #sustainability #manufacturing #cellandgenetherapy #patientcare #scaleready

How can next-gen tools to interrogate human biology and physiology at #scale, including the dynamic factors modulating health and disease over time, provide new information for more efficacious drug development? What can your zip code tell us about your health and your specific disease that your #genetic code cannot? Thank you to pharmaphorum and Nicole Raleigh for hosting Mo Jain, MD PhD on your latest #podcast to discuss these questions and evolving approaches to personalize disease prediction, diagnostics, and therapies. Check out the full conversation here: https://lnkd.in/gDi8vFhV

In this episode, I interview Julio Ribeiro Ph.D Medicine, MIEAust, founder of Inventia Life Science. Inventia is a science and technology company focused on building devices that can create advanced cell models that help accelerate drug discovery and biomedical research. Founded in 2013, Julio has grown the company to now have over 70 employees and scale internationally to the US, Europe and many more locations. Throughout the episode, Julio explains that creative freedom is one of the most important aspects when building products and the techniques he uses to foster it at Inventia. He also explains the unique troubles that scientific firms face such as the need to constantly invent new solutions and devices to make progress in their research and products. If you enjoy this episode, feel free to leave a 5 star review and share with family and friends. Podcast link: https://lnkd.in/d7ByjsDf #portfoliomanagement #investing #science #technology #familyoffice

Next-gen #tech is enabling #drugdiscovery at an entirely new scale, advancing #precisionmedicine and resulting in better #patientoutcomes. In a new pharmaphorum #podcast, Dr Mohit Jain, founder and CEO of #SapientBio, discusses #diseaseprediction, #diagnostics, and therapies with host Nicole R.. https://lnkd.in/eGAzWpFy

Join us on an important episode of BIO from the BAYOU! 🎙️ Discover the groundbreaking T-Vant, a revolutionary vaccine adjuvant developed by Tulane University's experts, Lisa Morici, PhD, and James McLachlan, PhD. Learn how T-Vant is set to transform the vaccine landscape. Don't miss insights on emerging innovations! 🌟 #VaccineInnovation #Biotech #TulaneUniversity #Podcast 🔗 Link in comments

New podcast: Are we close to an AI drug revolution? In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.  In this episode, Megan Thomas is in conversation with Dr Friso Postma, Vice President of AI Drug Discovery at BioXcel Therapeutics, Inc.. https://lnkd.in/e8svvUZq #AI #DrugDiscovery #ArtificialIntelligence

Excited to announce the teaser for the next episode of Technology in Science, 𝘼𝙄 𝙏𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢𝙞𝙣𝙜 𝘽𝙞𝙤𝙩𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮: 𝙄𝙣𝙣𝙤𝙫𝙖𝙩𝙞𝙤𝙣𝙨, 𝙄𝙣𝙨𝙞𝙜𝙝𝙩𝙨 𝙖𝙣𝙙 𝙄𝙢𝙥𝙖𝙘𝙩 💫 In this podcast I had the pleasure of speaking with Saverio Niccolini, the COO of NEC OncoImmunity and the General Manager of NEC Laboratories Europe. We dive into the intricate details of AI in Biotechnology, addressing groundbreaking innovations, leadership insights and the impact of AI research. Here is a sneak peak of our conversation, stay tuned for the full episode coming soon! #podcast #immunology #artificialintelligence #technology #science #bioinformatics #innovation #biotechnology

Check out the podcast below to learn more about Vivodyne and it's CEO & Co-Founder, Andrei Georgescu, Ph.D. on how they are de-risking drug development with their novel organ-on-a-chip technology.

Quick overview of: - ŌURA and Veri acquisition! What great news! - #NHS future - seems like digital innovations will be introduced and encouraged across the NHS to achieve its efficiency. - #investment - not going through every single round because there were many! This indicates that the market might become busier, encouraging innovation in medical fields. If you know any investors, let me know. I have a few clients who are also looking to raise this year or early 2025. - #podcast! I am super thrilled to work on the second episode which will include Digital Therapeutics topics, so watch the space. If you haven't had a chance to listen to our first episode, you can find the link in the comments below. #MedTechwithIndre #digitalhealth #Healthinnovation

Interested in the evolving landscape of peptide technology? This episode is a must-listen! Tune into our latest podcast episode featuring Dr. Nora Khaldi, a leading expert in biotechnology and founder of Nuritas. 🌟 Key Highlights: - Peptide Potential: Explore how peptides can support muscle health, enhance collagen production, and reduce inflammation—essential considerations for your patients' health. - Innovative Solutions: Discover the capabilities of the Nuritas peptide finder and how it can identify targeted ingredients for specific health concerns. - AI in Research: Dr. Khaldi shares her insights on integrating AI into scientific research, providing a glimpse into the future of product development in the health sector. As practitioners, understanding the latest advancements in supplementation is crucial for guiding patients toward optimal health outcomes. Don’t miss this opportunity to expand your knowledge! Listen here: https://brnw.ch/21wNPb0 #NewEpisode #Podcast #Peptides #HealthcareProfessionals #InnovationInHealth #Research